FMR LLC lessened its holdings in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 34.9% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 4,890,754 shares of the company's stock after selling 2,625,694 shares during the quarter. FMR LLC owned 2.87% of Option Care Health worth $113,466,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently modified their holdings of the business. Vanguard Group Inc. boosted its stake in Option Care Health by 0.4% in the fourth quarter. Vanguard Group Inc. now owns 19,315,421 shares of the company's stock valued at $448,118,000 after buying an additional 75,313 shares in the last quarter. Wellington Management Group LLP boosted its stake in shares of Option Care Health by 84.6% in the 4th quarter. Wellington Management Group LLP now owns 18,325,123 shares of the company's stock valued at $425,143,000 after purchasing an additional 8,400,208 shares in the last quarter. Norges Bank bought a new stake in shares of Option Care Health during the 4th quarter valued at approximately $60,219,000. Charles Schwab Investment Management Inc. increased its position in Option Care Health by 6.2% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 2,510,131 shares of the company's stock worth $58,235,000 after purchasing an additional 147,054 shares in the last quarter. Finally, Magnetar Financial LLC increased its position in Option Care Health by 23.1% during the 4th quarter. Magnetar Financial LLC now owns 2,350,598 shares of the company's stock worth $54,534,000 after purchasing an additional 441,265 shares in the last quarter. Institutional investors own 98.05% of the company's stock.
Wall Street Analyst Weigh In
OPCH has been the topic of a number of research reports. Bank of America raised shares of Option Care Health from a "neutral" rating to a "buy" rating and boosted their target price for the stock from $26.00 to $33.00 in a research note on Monday, January 13th. Barrington Research boosted their price objective on Option Care Health from $33.00 to $38.00 and gave the stock an "outperform" rating in a research report on Thursday, February 27th. JPMorgan Chase & Co. increased their target price on Option Care Health from $40.00 to $41.00 and gave the company an "overweight" rating in a research report on Thursday, March 6th. Jefferies Financial Group upgraded Option Care Health from a "hold" rating to a "buy" rating and boosted their price target for the stock from $26.00 to $35.00 in a report on Thursday, January 23rd. Finally, JMP Securities reiterated a "market outperform" rating and issued a $30.00 price objective (down previously from $31.00) on shares of Option Care Health in a report on Friday, January 10th. Two research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company's stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $33.00.
View Our Latest Stock Report on OPCH
Option Care Health Trading Down 0.6 %
Shares of NASDAQ:OPCH traded down $0.19 during trading on Friday, reaching $32.09. The stock had a trading volume of 1,835,227 shares, compared to its average volume of 1,795,968. Option Care Health, Inc. has a 52 week low of $21.39 and a 52 week high of $35.53. The firm's fifty day moving average is $33.33 and its 200 day moving average is $28.66. The stock has a market cap of $5.27 billion, a price-to-earnings ratio of 26.96, a P/E/G ratio of 2.30 and a beta of 1.07. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73.
Insider Buying and Selling at Option Care Health
In other news, insider Michael Bavaro sold 30,996 shares of the business's stock in a transaction dated Friday, February 28th. The stock was sold at an average price of $33.26, for a total value of $1,030,926.96. Following the transaction, the insider now directly owns 44,974 shares of the company's stock, valued at $1,495,835.24. The trade was a 40.80 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Insiders own 0.64% of the company's stock.
About Option Care Health
(
Free Report)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
See Also
Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
